Association between the generation of cephalosporins for perioperative prophylaxis and postoperative surgical site infections in open fractures: a prospective cohort study

Gespeichert in:
Bibliographische Detailangaben
Titel: Association between the generation of cephalosporins for perioperative prophylaxis and postoperative surgical site infections in open fractures: a prospective cohort study
Autoren: Yang, Zhenbang, Meng, Hongyu, Li, Junyong, Du, Pei, Lv, Hongzhi, Zhao, Kuo, Zhang, Junzhe, Li, Ming, Jin, Zhucheng, Peng, Ziheng, Ye, Dandan, Ding, Kai, Song, Zhaohui, Wang, Juan, Xing, Xin, Zhu, Yanbin, Zhang, Yingze, Chen, Wei
Quelle: Int J Surg
Verlagsinformationen: Ovid Technologies (Wolters Kluwer Health), 2025.
Publikationsjahr: 2025
Schlagwörter: Prospective Cohort Study
Beschreibung: Background: The use of cephalosporins for surgical site infection (SSI) prevention has become a clinical routine, however, high-level evidence regarding the optimal generation for open fractures is currently limited. This study aims to investigate the association between the generation of cephalosporins and SSI risk in open fractures. Methods: This prospective cohort study used data from the Surgical Site Infection in Orthopedic Surgery (SSIOS), a prospectively maintained database, conducted at a tertiary orthopedic university hospital from October 2014 to December 2020. The primary outcome was occurrence of SSI within 1 year after operation, and its association with the generation of cephalosporins was examined using multivariable logistic regressions and generalized estimating equations. Generalized additive models were used to calculate the relative contribution of potential factors likely influencing SSI. Results: A total of 3582 eligible patients, 74.6% males, with a mean age of 43.7 ± 14.1 years, were included. First-, second-, and third-generation cephalosporins were used in 1957 (54.6%), 1219 (34.0%), and 406 (11.3%) patients. Compared to first-generation cephalosporins, the use of second-generation cephalosporins was significantly associated with a higher risk of SSI (absolute risk difference [ARD] = 3.70%; 95% CI, 1.90%–5.51%; adjusted OR [aOR] = 1.604; 95% CI, 1.212–2.124), whereas third-generation cephalosporins were not (ARD = 1.02%; 95% CI, −1.78% to 3.82%; aOR = 1.234; 95% CI, 0.790–1.880). Among the 28 potential factors considered, the generation of cephalosporins was ranked 9th in terms of its impact on the risk of SSI. Conclusion: Perioperative use of higher-generation cephalosporins was not associated with a reduction in postoperative surgical site infections in open fractures. Our study supports existing guidelines that recommend the use of first-generation cephalosporins as the preferred agents for preventing SSIs in open fractures.
Publikationsart: Article
Other literature type
Sprache: English
ISSN: 1743-9159
DOI: 10.1097/js9.0000000000002371
Rights: CC BY
URL: http://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (http://creativecommons.org/licenses/by/4.0/) (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Dokumentencode: edsair.doi.dedup.....d2c007b9c492702aa42716e8adf43518
Datenbank: OpenAIRE
Beschreibung
Abstract:Background: The use of cephalosporins for surgical site infection (SSI) prevention has become a clinical routine, however, high-level evidence regarding the optimal generation for open fractures is currently limited. This study aims to investigate the association between the generation of cephalosporins and SSI risk in open fractures. Methods: This prospective cohort study used data from the Surgical Site Infection in Orthopedic Surgery (SSIOS), a prospectively maintained database, conducted at a tertiary orthopedic university hospital from October 2014 to December 2020. The primary outcome was occurrence of SSI within 1 year after operation, and its association with the generation of cephalosporins was examined using multivariable logistic regressions and generalized estimating equations. Generalized additive models were used to calculate the relative contribution of potential factors likely influencing SSI. Results: A total of 3582 eligible patients, 74.6% males, with a mean age of 43.7 ± 14.1 years, were included. First-, second-, and third-generation cephalosporins were used in 1957 (54.6%), 1219 (34.0%), and 406 (11.3%) patients. Compared to first-generation cephalosporins, the use of second-generation cephalosporins was significantly associated with a higher risk of SSI (absolute risk difference [ARD] = 3.70%; 95% CI, 1.90%–5.51%; adjusted OR [aOR] = 1.604; 95% CI, 1.212–2.124), whereas third-generation cephalosporins were not (ARD = 1.02%; 95% CI, −1.78% to 3.82%; aOR = 1.234; 95% CI, 0.790–1.880). Among the 28 potential factors considered, the generation of cephalosporins was ranked 9th in terms of its impact on the risk of SSI. Conclusion: Perioperative use of higher-generation cephalosporins was not associated with a reduction in postoperative surgical site infections in open fractures. Our study supports existing guidelines that recommend the use of first-generation cephalosporins as the preferred agents for preventing SSIs in open fractures.
ISSN:17439159
DOI:10.1097/js9.0000000000002371